The GRIB, BAPP, NEUROPHAR and IAT research groups hosted last 19th November a meeting about the European Initiative IMI.

This event attracted some of the most relevant companies and initiatives in the current Spanish scenario, like Laboratoris Almirall, Esteve, GlaxoSmithKline, Progenika, Lundbeck, Faes Farma, Ordesa and Ferrer, among others.

The meeting was composed by three main blocks,

• Presentation of the IMI current status and future perspectives.
• Presentation of the main research lines of GRIB, NEUROPHAR, BAPP and IAT related to IMI.
• The vision of the Industry

At the end of the event, a work lunch took place at "Ca la Nuri" restaurant